Search Results - "Arkema, E V"

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab by Neovius, M, Arkema, E V, Olsson, H, Eriksson, J K, Kristensen, L E, Simard, J F, Askling, J

“…To compare drug survival on adalimumab, etanercept and infliximab in patients with rheumatoid arthritis (RA). Patients with RA (n=9139; 76% women; mean age 56…”
Get more information

Sick leave and disability pension following delivery in women with systemic lupus erythematosus by Grannas, D, Simard, J F, Svenungsson, E, Arkema, E V, Gernaat, Sam

“…To investigate sickness benefits following delivery in mothers with systemic lupus erythematosus (SLE) and mothers without SLE. SLE and non-SLE mothers,…”
Get full text

Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission by Kuriya, B, Arkema, E V, Bykerk, V P, Keystone, E C

“…The target outcome in early rheumatoid arthritis (ERA) is now remission. This meta-analysis compared the efficacy of initial methotrexate monotherapy versus…”
Get more information

Infections increase the risk of developing Sjögren's syndrome by Mofors, J., Arkema, E. V., Björk, A., Westermark, L., Kvarnström, M., Forsblad‐d'Elia, H., Magnusson Bucher, S., Eriksson, P., Mandl, T., Nordmark, G., Wahren‐Herlenius, M.

“…Objective Environmental factors have been suggested in the pathogenesis of rheumatic diseases. We here investigated whether infections increase the risk of…”
Get full text

Endometriosis and systemic lupus erythematosus: a population-based case–control study by Harris, H R, Simard, J F, Arkema, E V

“…Objective To investigate the association between endometriosis and systemic lupus erythematosus (SLE) in prospectively collected population-based data. Methods…”
Get full text

Perinatal risk factors for future SLE: a population-based nested case-control study by Arkema, E V, Simard, J F

“…Objective To investigate the association between perinatal characteristics and the offspring’s risk of lupus using population-based registers in Sweden…”
Get full text

PO.7.162 Epidemiology of systemic lupus erythematosus in central Sweden: a population-based cohort study from the östergötland county over 14 years by Arkema, EV, Saleh, M, Simard, JF, Sjöwall, C

“…PurposeWe examined variations in incidence and prevalence of systemic lupus erythematosus (SLE) within a geographically defined area of central Sweden over a…”
Get full text

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers by Hellgren, Karin, Dreyer, Lene, Arkema, Elizabeth V, Glintborg, Bente, Jacobsson, Lennart T H, Kristensen, Lars-Erik, Feltelius, Nils, Hetland, Merete Lund, Askling, Johan

“…Safety data on cancer risks following tumour necrosis factor α inhibitors (TNFi) in patients with spondyloarthritis (SpA) (here defined as ankylosing…”
Get more information

The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data by Eriksson, JK, Askling, J, Arkema, EV

Get full text

Dr. Rossides, et al reply by Rossides, Marios, Simard, Julia F, Svenungsson, Elisabet, VON Euler, Mia, Arkema, Elizabeth V

Get full text

The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data by Eriksson, J K, Askling, J, Arkema, E V

“…New therapeutic options are constantly emerging for the treatment of rheumatic diseases. To evaluate the safety and efficacy of newly introduced anti-rheumatic…”
Get full text

Ten years with biologics: to whom do data on effectiveness and safety apply? by Simard, Julia F, Arkema, Elizabeth V, Sundström, Anders, Geborek, Pierre, Saxne, Tore, Baecklund, Eva, Coster, Lars, Dackhammar, Christina, Jacobsson, Lennart, Feltelius, Nils, Lindblad, Staffan, Rantapää-Dahlqvist, Solbritt, Klareskog, Lars, van Vollenhoven, Ronald F, Neovius, Martin, Askling, Johan

“…During the past decade, the position of biologics in the therapeutic armamentarium, the number of approved indications and the number of available biologics…”
Get full text

Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors by Arkema, Elizabeth V, Cozier, Yvette C

“…PURPOSE OF REVIEWThe aim of this review is to describe the latest studies on sarcoidosis incidence, prevalence and risk factors with a special focus on reports…”
Get full text

Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden by Arkema, Elizabeth V, Grunewald, Johan, Kullberg, Susanna, Eklund, Anders, Askling, Johan

“…Our objective was to estimate the contemporary incidence and prevalence of sarcoidosis using Swedish population-based register data.Adults with any…”
Get full text

Sarcoidosis: Epidemiology and clinical insights by Rossides, Marios, Darlington, Pernilla, Kullberg, Susanna, Arkema, Elizabeth V.

“…Sarcoidosis is characterized by noncaseating granulomas which form in almost any part of the body, primarily in the lungs and/or thoracic lymph nodes…”
Get full text

History and familial aggregation of immune-mediated diseases in sarcoidosis: a register-based case-control-family study by Rossides, Marios, Kullberg, Susanna, Arkema, Elizabeth V

“…An autoimmune component in the etiology of sarcoidosis has long been debated, but population-based data on the clustering of immune-mediated diseases (IMD) and…”
Get full text

Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis by Bairkdar, Majd, Rossides, Marios, Westerlind, Helga, Hesselstrand, Roger, Arkema, Elizabeth V, Holmqvist, Marie

“…Abstract Objectives We aimed to conduct a systematic review and meta-analysis on the incidence and prevalence of SSc covering the entire literature. Methods…”
Get full text

Sarcoidosis by Grunewald, Johan, Grutters, Jan C., Arkema, Elizabeth V., Saketkoo, Lesley Ann, Moller, David R., Müller-Quernheim, Joachim

“…Sarcoidosis is an inflammatory disorder of unknown cause that is characterized by granuloma formation in affected organs, most often in the lungs. Patients…”
Get full text

Epidemiology of sarcoidosis: current findings and future directions by Arkema, Elizabeth V., Cozier, Yvette C.

“…Sarcoidosis is a granulomatous inflammatory disease with unknown etiology. Epidemiological studies have contributed greatly to our knowledge about sarcoidosis,…”
Get full text

Epidemiology of Sarcoidosis by Cozier, Yvette C., Arkema, Elizabeth V.

“…Sarcoidosis is a systemic, granulomatous disease with variable presentation earning it the term “the great mimicker.” The current epidemiology confirms that…”
Get full text